Related Experiment Videos
Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease
M C Dubinsky1, J J Ofman, M Urman
1Department of Pediatrics, University of Montreal, Quebec, Canada.
Insights
This study shows that combining modified serodiagnostic tests for pediatric inflammatory bowel disease (IBD) improves diagnostic accuracy. This sequential testing strategy can reduce unnecessary invasive investigations in children with unclear symptoms.
Area of Science:
- Pediatric Gastroenterology
- Immunology
- Diagnostic Medicine
Background:
- Nonspecific symptoms in children often complicate the diagnosis of inflammatory bowel disease (IBD).
- Accurate, non-invasive screening tests are needed to differentiate IBD from functional disorders, avoiding invasive procedures.
- Modified serodiagnostic assays, including anti-Saccharomyces cerevisiae antibody (ASCA) and perinuclear antineutrophil cytoplasmic antibody (pANCA), aim to improve sensitivity and specificity.
Purpose of the Study:
- To evaluate the diagnostic accuracy of combined modified serodiagnostic tests for IBD in pediatric patients.
- To determine if a sequential testing strategy using these assays can minimize invasive diagnostic investigations.
- To assess the potential reduction in unnecessary procedures through improved diagnostic decision-making.
Main Methods:
- Prospective study of 128 pediatric patients undergoing IBD evaluation, with blinded assessment of ASCA, ANCA, and pANCA profiles.
- Phase I: Compared diagnostic accuracy and predictive values of modified vs. traditional serodiagnostic assays.
- Phase II: Assessed the accuracy of a novel sequential diagnostic testing strategy and calculated avoided invasive investigations.
Main Results:
- The modified serodiagnostic assay demonstrated higher sensitivity (81% vs. 69%) for IBD detection.
- The traditional assay offered higher specificity (96% vs. 72%) for IBD.
- The sequential testing strategy achieved 84% overall accuracy and could have reduced false-positive diagnoses by 81%.
Conclusions:
- Sequential non-invasive serodiagnostic testing enhances diagnostic accuracy for pediatric IBD.
- This strategy can significantly reduce the need for costly and invasive diagnostic evaluations.
- Improved clinical decision-making is facilitated when IBD diagnosis in children is initially uncertain.
Objectives:
Confronted with nonspecific symptoms, accurate screening tests would be useful to clinicians to distinguish between functional childhood disorders and inflammatory bowel disease (IBD), thus avoiding invasive diagnostic testing. Traditional ulcerative colitis-specific perinuclear antineutrophil cytoplasmic antibody (pANCA) and Crohn's disease-specific anti-Saccharomyces cerevisiae antibody (ASCA) serodiagnostic assays have recently been modified, with ELISA cut-off values recalculated to maximize sensitivity. The aim of this study was to determine whether the combination of these serodiagnostic tests could maximize diagnostic accuracy and minimize invasive investigations in pediatric patients presenting with nonspecific symptoms suggestive of IBD.
Methods:
With investigators blinded to clinical diagnoses, ASCA, ANCA, and pANCA profiles were obtained prospectively from 128 patients undergoing complete diagnostic evaluation for IBD. In phase I, diagnostic accuracy and predictive values of the modified and traditional assays were compared for the IBD (n = 54) and non-IBD groups (n = 74). In phase II, the overall accuracy of a novel sequential diagnostic testing strategy was determined. Additionally, the potential number of invasive investigations avoided with the hypothetical application of this strategy to the cohort was determined.
Results:
For phase I, the modified serodiagnostic assay was more sensitive (81 vs 69%), whereas the traditional assay had a higher specificity (96 vs 72%) for IBD (p < 0.05) For phase II, false-positive diagnoses would have been reduced by 81%, yielding an overall sequential testing strategy accuracy of 84%.
Conclusions:
The incorporation of sequential noninvasive testing into a diagnostic strategy may avoid unnecessary and costly evaluations and facilitate clinical decision making when the diagnosis of IBD in children is initially uncertain.